Clinical trial
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid…
NCT00002677 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00002677 |
|---|---|
| Title | Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors |
| Official title | PHASE I STUDY OF THE ORALLY ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | chemotherapy, tributyrin |
| Enrollment | 24 |
| Start date | Aug 1, 1995 |
| Primary completion | Mar 1, 2003 |
| Completion | Mar 1, 2003 |
| First posted | May 11, 2004 |
| Last update posted | Nov 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: